KRAS and neoplasm: These mutations included eight tumor suppressors: Apc, Tp53, Fbxw7, Tgfbr2, Smarca4, Fat4, Mapk14, and Cdh1, along with one oncogenic mutation in Kras (Supplementary Table 15).